EDGAR·FLOW

Liquidia Corp — Form 8-K

Filed September 30, 2026 · analyzed by the 8-K Agent
8-K ▼ Likely negative significance 76/100
What the filing says
U.S. District Court for Delaware found that claims 1 and 14 of United Therapeutics' U.S. Patent No. 11,826,327 are valid and infringed by Liquidia's YUTREPIA (treprostinil) inhalation powder; four other asserted claims were ruled invalid. Parties must submit proposed remedies within one week. UTHR is seeking injunctive relief that could restrict or block YUTREPIA's market availability, though Liquidia plans to appeal and remove the PH-ILD indication from the label.
Why this rating

Partial patent loss on lead product (launched 2025) threatens major revenue stream; injunction risk is material to ~$847M market-cap company; label restriction or market block would be transformational damage.

Tradability signal
SHORT conviction 42/100 · expected -1.15% over 4 hrs

SHORT (drift): bad news keeps sliding after dissemination — our one persistent measured edge. Similar past filings (35 in this cell) moved +1.98% in the called direction over 4 hrs; shrunk for sample size that's a +1.15% edge. Price is down 22.4% since the filing hit EDGAR — the slide has begun. Exit plan: HARD stop 8% against entry — 1.4× this stock's measured hourly volatility, fixed, not trailing (trails test terribly on these names) — time exit 4 hrs. (Filing arrived outside market hours — evaluated at the next open with a live quote.)

Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.

Price action (we called it negative)
before filing · preread
$30.29 ▲ 34.33%
at our read · unknown
$22.55
+10 min · unknown
$25.57 ▲ 13.41%
+30 min · unknown
$25.44 ▲ 12.82%
+1 hr · unknown
$26.03 ▲ 15.43%
+4 hrs · unknown
$26.73 ▲ 18.55%

The stock had already moved -25.56% between hitting EDGAR and our read finishing — deltas above are measured from our read.

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ LQDA · stock on Yahoo Finance ↗

See more from September 30, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.